Comparison
NMN vs PQQ
NMN
Nicotinamide mononucleotide — NAD+ precursor. Studied for cellular aging and metabolic health.
PQQ
Pyrroloquinoline quinone — cofactor in mitochondrial biogenesis. Found in fermented foods and breast milk.
| Field | NMN | PQQ |
|---|---|---|
| Category | neuroprotective | neuroprotective |
| Dose range | 250–1000mg | 10–40mg |
| Half-life | — | — |
| Onset | — | — |
| Evidence | EVIDENCEB | EVIDENCEC |
| Safety | ●●●●● | ●●●●● |
| Legal (US) | USOTC | USOTC |
| PubMed refs | 600 | 320 |
The comparison in plain English
Auto-generated from dataNMN and PQQ are both in the neuroprotective category respectively. NMN Nicotinamide mononucleotide — NAD+ precursor. PQQ Pyrroloquinoline quinone — cofactor in mitochondrial biogenesis.
Bottom line
NMN (evidence B, safety 5/5) has a weaker evidence base than PQQ (evidence C, safety 5/5). NMN has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.
Choose NMN if
NMN is the better fit when your goal aligns with its mechanism (Direct precursor to NAD+ — one biosynthetic step closer than nicotinamide riboside, bypassing the NRK1/NRK2 enzymatic step) and the dose range (250–1000mg) suits your protocol. Half-life is —h.
Choose PQQ if
PQQ is the better fit when your goal aligns with its mechanism (Pyrroloquinoline quinone uniquely stimulates mitochondrial biogenesis via the PGC-1α pathway — it doesn't just improve existing mitochondrial function but creates new mitochondria) and the dose range (10–40mg) suits your protocol. Half-life is —h.